Bank stocks have pulled the ASX200 up 0.2% to 5,632.9 points. The Shanghai Stock Exchange Composite Index rose 0.93% while in pre-open markets the Dow Mini lost 28 points to 16,793.
The first-in-main trial for the personalised therapeutic human cancer vaccine is scheduled to begin in the first quarter of 2015. This has the potential to target a wide range of hard-to-treat cancers with a single product.
The discovery of large flake graphite mineralisation at Triton Mineral’s Balama South Project in Mozambique is interesting given the physical similarities of its outcropping with that at the Balama North Project.
With WPG Resources' Bob Duffin intent on fast tracking the Tarcoola gold project into production in South Australia in quick time, through conventional open pit operation with associated heap leach processing, it could be producing 20,000 ounces of gold per year.
The company’s net operating positive cash flow of $1.35 million for the first six months of 2014 is well above the $246,000 it made in the full year to 31 December 2013. The acquisition of Warrior Forum in April and the introduction of Warrior Payments should further expand its cash flow for the world's largest outsourcing marketplace.
Although still early days for MRL Corporation in Sri Lanka, the analytical results of 99.2% Total Carbon highlight the prospectivty of the area. With diamond drilling ongoing, near-term newsflow will continue.
With potential for development into a small scale coking coal operation, the initial 20 hole drilling program at Aspire Mining and Noble Group’s Nuurstei Coal Project will be closely watched.
By adding Kam Lung Investment Development Company as a strategic investor, South Boulder now have a Chinese partner to potentially secure an offtake agreement. South Boulder's shares are expected to climb today.
Drilling continues to deliver high grade copper with many more samples to be assayed while a resource upgrade expected in August with a PFS in September, giving plenty to discuss. KGL Resources managing director Simon Milroy will present at the Melbourne Investor Luncheon.
With overall sales of $7.8 million for the year ended 30 June 2014, up from $7.4 million in the previous year, and closing cash of $19.5 million, Admedus is in a strong position to progress the launch and marketing of CardioCel® in Europe and the U.S.
With gold production from Millennium Mineral's Nullagine Gold Project in Western Australia coming in at the upper end of its guidance and a restated Resource expected this quarter, managing director Brian Rear will have much to discuss with investors in Melbourne. Register today.
The shallow Muga Potash Project in Spain, which is a shallow sylvinite project in the south eastern section of the new Muga-Vipasca project area has emerged as the company’s target for initial mine. EMR Capital has a 26.4% interest in the company.